Pro Share Advisors LLC Stoke Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$17.19 - $26.1 $160,657 - $243,930	-9,346 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$18.11 - $30.72 $17,168 - $29,122	-948 Reduced 9.21%	9,346 $224,000
Q3 2021 Nov 12, 2021	SELL	$23.65 - $34.44 $29,680 - $43,222	-1,255 Reduced 10.87%	10,294 $262,000
Q2 2021 Aug 13, 2021	BUY	$30.53 - $41.09 $88,842 - $119,571	2,910 Added 33.68%	11,549 $389,000
Q1 2021 May 14, 2021	BUY	$36.08 - $69.81 $10,824 - $20,943	300 Added 3.6%	8,639 $336,000
Q4 2020 Feb 09, 2021	BUY	$33.62 - $61.93 $49,824 - $91,780	1,482 Added 21.61%	8,339 $516,000
Q3 2020 Nov 13, 2020	BUY	$22.23 - $37.48 $152,431 - $257,000	6,857 New	6,857 $230,000
Q1 2020 May 15, 2020	SELL	$16.8 - $34.15 $139,725 - $284,025	-8,317 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$20.01 - $30.79 $166,423 - $256,080	8,317 New	8,317 $236,000

117

55.6M

14K

8.8K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $484M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.